clinics offering tirzepatide injections for weight loss Medical Tirzepatide Weight Loss Injections •

All tirzepatidetreated participants achieved at least 5% weight loss and 45% achieved at least 10% weight loss, compared with 9% and 0%, respectively, in the placebo group [9]

You may qualify for a prescription if you: Have type 2 diabetes and are struggling with insulin resistance

Semaglutide and Tirzepatide: The Differences The difference between the 2 medications lies in tirzepatides ability to mimic the GLP-1 hormone and the glucose-dependent insulinotropic polypeptide (GIP)

R., Lauwerys, R

The Phase 3 ATTAIN-1 trial showed the 36 mg dose achieved 11.2% mean body weight reduction over 72 weeks

These include chest pain or tightness, severe headaches, palpitations or irregular heartbeat, difficulty breathing, severe dizziness or fainting, or sudden vision changes